XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flows From Operating Activities:    
Net loss $ (127,122) $ (33,935)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 2,567 2,608
Share-based compensation expense 105,893 18,620
Non-cash operating leases expense 1,579 1,519
Amortization of premium on marketable securities 974 231
Provision for doubtful accounts 108 44
Other 2,891 1,053
Changes in operating assets and liabilities:    
Accounts receivable 974 (2,944)
Settlements receivable (2,584) 137
Network incentives receivable (20,002) (3,426)
Prepaid expenses and other assets (6,089) (1,439)
Accounts payable 282 (314)
Revenue share payable 9,992 26,559
Accrued expenses and other liabilities 34,037 20,751
Operating lease liabilities (2,147) (890)
Net cash provided by operating activities 1,353 28,574
Cash flows from investing activities:    
Purchases of property and equipment (2,251) (2,151)
Purchases of marketable securities (375,089) (183,367)
Sales of marketable securities 0 71,981
Maturities of marketable securities 114,688 72,190
Net cash used in investing activities (262,652) (41,347)
Cash flows from financing activities:    
Proceeds from initial public offering, net of underwriters’ discounts and commissions 1,319,809 0
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs 0 166,942
Proceeds from exercise of stock options, including early exercised stock options 2,872 1,744
Proceeds from exercise of warrants 60 0
Taxes paid related to net share settlement of restricted stock units (18,448) 0
Payment of deferred offering costs (3,134) (1,231)
Repurchase of early exercised unvested options (73) (66)
Net cash provided by financing activities 1,301,086 167,389
Net increase in cash, cash equivalents, and restricted cash 1,039,787 154,616
Cash, cash equivalents, and restricted cash- Beginning of period 228,233 68,144
Cash, cash equivalents, and restricted cash - End of period $ 1,268,020 $ 222,760